Skip to content
★ Sign in to follow
RA

Robert A. Gunst

Iridex CorpNatus Medical Inc
Total declarations
64
Companies
2
▲ Purchases (3 ops.)
€141k
▼ Sales (33 ops.)
€3.2M

Latest filing published 26 Jun 2020 for IRIDEX CORP.

Filing timeline

BuySale
Robert A. Gunst

Insider track record

Disclosed buys
3
Disclosed sells
33
Signal history

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Robert A. Gunst: trading record in brief

Robert A. Gunst has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Natus Medical Inc and Iridex Corp. In total, 64 filings cover trades dated from 27 February 2006 to 24 June 2020.

On the open market, the record shows 3 purchases worth €141k and 33 sales worth €3.2M. The net balance comes to €3.0M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 16 share grants and 12 option exercises.

Half of the purchases are above €51k and half below.

Most recently, on 26 June 2020, the filings show a share grant in Iridex Corp. The latest purchase dates back some time: it was published 4,987 days ago, on 14 March 2013. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Robert A. Gunst

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations63 total
  • ◆
    DirectorExecutivesIridex Corp
    0SEC
    22,935 shares0Common StockSEC:0001209191-20-039139:0
  • ◆
    DirectorExecutivesIridex Corp
    0SEC
    4,329 shares0Common StockSEC:0001209191-19-059425:0
  • ◆
    DirectorExecutivesIridex Corp
    0SEC
    11,204 shares0Common StockSEC:0001209191-19-043260:0
  • ▼
    DirectorExecutivesNatus Medical Inc
    52,500 USD23SEC
    2,000 shares@ US$26.252.9% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-19-000065:0
  • ▼
    DirectorExecutivesNatus Medical Inc
    107,520 USD24SEC
    4,000 shares@ US$26.886.0% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-19-000065:1
  • ▼
    DirectorExecutivesNatus Medical Inc
    53,840 USD23SEC
    2,000 shares@ US$26.923.0% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-19-000065:2
  • ▼
    DirectorExecutivesNatus Medical Inc
    119,651 USD12SEC
    4,304 shares@ US$27.806.6% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-19-000047:0
  • ▼
    DirectorExecutivesNatus Medical Inc
    56,600 USD11SEC
    2,000 shares@ US$28.303.1% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-19-000047:1
  • ▼
    DirectorExecutivesNatus Medical Inc
    57,000 USD11SEC
    2,000 shares@ US$28.503.1% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-19-000047:2
  • ◇
    DirectorExecutivesNatus Medical Inc
    71,700 USD11SEC
    5,000 shares@ US$14.343.9% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-19-000040:0
  • ◇
    DirectorExecutivesNatus Medical Inc
    73,500 USD11SEC
    3,000 shares@ US$24.504.0% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-19-000040:1
  • ▼
    DirectorExecutivesNatus Medical Inc
    104,745 USD12SEC
    3,696 shares@ US$28.345.8% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-19-000040:2
  • ▼
    DirectorExecutivesNatus Medical Inc
    494,715 USD14SEC
    14,750 shares@ US$33.5427.0% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-18-000165:0
  • ▼
    DirectorExecutivesNatus Medical Inc
    170,850 USD12SEC
    5,000 shares@ US$34.179.1% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-18-000132:0
  • ▼
    DirectorExecutivesNatus Medical Inc
    139,523 USD12SEC
    4,100 shares@ US$34.037.5% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-18-000132:1
  • ▼
    DirectorExecutivesNatus Medical Inc
    116,640 USD12SEC
    3,240 shares@ US$36.006.2% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-18-000132:2
  • ▼
    DirectorExecutivesNatus Medical Inc
    18,025 USD11SEC
    500 shares@ US$36.051.0% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-18-000132:3
  • ◆
    DirectorExecutivesNatus Medical Inc
    149,992 USD12SEC
    4,132 shares@ US$36.308.0% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-18-000106:0
  • ◇
    DirectorExecutivesNatus Medical Inc
    53,450 USD11SEC
    5,000 shares@ US$10.691.7% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-18-000055:0
  • ▼
    DirectorExecutivesNatus Medical Inc
    154,748 USD12SEC
    4,400 shares@ US$35.175.0% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-17-000080:0
  • ◆
    DirectorExecutivesNatus Medical Inc
    145,960 USD12SEC
    4,100 shares@ US$35.605.0% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-17-000056:0
  • ◇
    DirectorExecutivesNatus Medical Inc
    81,900 USD11SEC
    5,000 shares@ US$16.383.0% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-17-000015:0
  • ▼
    DirectorExecutivesNatus Medical Inc
    180,000 USD12SEC
    5,000 shares@ US$36.006.5% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-17-000015:1
  • ▼
    DirectorExecutivesNatus Medical Inc
    136,240 USD11SEC
    3,250 shares@ US$41.924.8% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-16-000199:0
  • ◆
    DirectorExecutivesNatus Medical Inc
    147,224 USD12SEC
    4,400 shares@ US$33.465.1% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-16-000157:0

25 of 63 declarations